Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company

Refine Search
Asia
An Indian company is working on two approaches to creating a vaccine for the Zika virus, while several trademark applications have been filed for the term. Lucy Rana of SS Rana reports.   8 June 2016
Africa
Africa Harvest is working towards reducing hunger and poverty in some of the world’s poorest countries. Dr Florence Wambugu, founder of the organisation, tells LSIPR more about its work.   8 June 2016
Americas
Hollywood actor Will Smith has praised the power of science and the work of neuropathologist Dr Bennet Omalu during a speech at the 2016 BIO International Convention.   8 June 2016
Americas
Aided by strong patent protection, efforts are continuing in Brazil to develop a vaccine against the notorious dengue fever. Gabriel Di Blasi of Di Blasi, Parente & Associados and Jorge Kalil of the Instituto Butantan explain more.   8 June 2016
Americas
There are several rules to watch out for when seeking patent protection for antibodies in Brazil, as Kene Gallois of Daniel Advogados reports.   8 June 2016
Africa
The president of Nigeria’s Senate has proposed that people convicted of selling counterfeit drugs and food are jailed for life and fined up to ₦2 million dollars.   7 June 2016
Americas
Merial, which is well-known for making products that kill fleas and ticks on cats and dogs, faces a number of challenges on the IP front, as global head of IP Dr Judy Jarecki-Black, tells LSIPR.   7 June 2016
Biotechnology
LSIPR spoke to Dr Claire Skentelbery of the ENABLE project about the need for novel developments and the importance of a solid intellectual property strategy.   7 June 2016
Africa
For something to be innovative it must “add value” and companies must ensure they understand the term in order to succeed, the 2016 BIO International Convention has heard.   7 June 2016
Americas
The 2016 BIO International Convention has heard that drug companies are on a mission to discover new tools to support the development of anti-infectives due to a decrease in the development of new antibiotics.   7 June 2016